Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Markets rangebound as investors digest earnings and data
(Sharecast News) - European stock markets were rangebound on Tuesday as risk appetite remains limited ahead of a number of key risk events in the coming days, while traders assessed a barrage of blue-chip corporate earnings and economic data.
The markets gave mixed reactions to quarterly results from heavyweights HSBC, Novartis, Banco Santander and BP, as investors also awaited earnings figures from a number of US giants this week - including five of the Magnificent Seven tech stocks.
Underlying concerns about the Middle East, nervousness ahead of the UK autumn budget on Wednesday and the US non-farm payrolls report on Friday, as well as ongoing uncertainty surrounding the US presidential elections next week, were all combining to keep a lid on gains in morning trade, according to analysts.
The Stoxx 600 was more or less flat at 521.17 by 1256 CET, with just two points separating the index's intraday high and low.
In economic news, the forward-looking GfK/NIM German consumer climate index for November rose by 2.7 points to -18.3 from October's revised -21.0. This is the highest level since April 2022, although confidence remains low. "The uncertainty caused by crises, wars and rising prices is still very much present and is preventing factors that encourage consumption, e.g. the real income growth, from taking full effect," said Rolf Buerkl, consumer expert at NIM.
In the UK, shop prices were 0.8% lower in October than 12 months ago, compared with a 0.6% year-on-year fall in September, according to the BRC/NielsenIQ Shop Price Index. This was the third straight month of annual deflation and lowest rate of change since August 2021.
In other news, Swedish GDP contracted by 0.1% in the third quarter after a 0.3% decline in the second, meaning that the economy entered a technical recession, according to government statistics. Economists had pencilled in a 0.4% rebound.
Meanwhile, oil prices were partially rebounding after tanking more than 5% on Monday after airstrikes sent from Israel to Iran avoided oil and nuclear facilities, easing concerns of disruptions to supply. Brent crude was up 1.2% at $71.85 a barrel.
Blue chip earnings
HSBC rose 4% after announcing another $3bn share buyback as it posted better-than-expected third-quarter profits, underpinned by solid performances from the wealth and investment banking units. In the three months to the end of September, pre-tax profit rose 10% on the same period a year earlier to $8.5bn, versus analysts' expectations of $7.6bn.
Other banks were also on the rise in Europe, including Deutsche Bank, Commerzbank, Societe Generale and Standard Chartered.
However, Banco Santander dropped nearly 3% in Madrid after the news that it had delayed the release of its UK results - as it assess the impact of a landmark ruling on motor finance commissions that could cost hundreds of millions of euros - overshadowed a record third-quarter profit that beat forecasts.
Swiss pharma giant Novartis slumped despite lifting profit guidance for the third time this year following a forecast-beating third quarter. The company said annual core operating profit growth would be in the high-teens, compared with a previous estimate of mid- to high-teens growth. But shares dropped more than 3% as the market focused of mixed results for individual drug sales.
BP posted a slide in quarterly profits, hit by weaker refining margins, although the decline was not as steep as feared. However, shares fell with sentiment in the oil sector still weighed down by the sharp drop in the price of the commodity the previous day.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.